Home > Boards > US Listed > Banking and Finance > GSC Investment (GNV)

well, looks like Im a bagholder for awhile

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Alex Chory Member Profile
 
Followed By 6
Posts 7,490
Boards Moderated 0
Alias Born 11/25/04
160x600 placeholder
Alex Chory   Monday, 05/19/08 04:22:35 PM
Re: MACH2 post# 488
Post # of 585 
well, looks like Im a bagholder for awhile in HBIO, never fukking FAILS

http://pinksheets.com/edgar/GetFilingPdf?FilingID=5946220

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549




FORM S-8

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933






HARVARD BIOSCIENCE, INC.


(Exact Name of Registrant as Specified in Its Charter)







Delaware 84 October Hill Road

Holliston, Massachusetts 01746

(508) 893-8999
04-3306140
(State of Incorporation) (Address of Registrant’s principal executive offices) (I.R.S. Employer Identification No.)






HARVARD BIOSCIENCE, INC.

SECOND AMENDED AND RESTATED 2000

STOCK OPTION AND INCENTIVE PLAN

(Full Title of the Plan)




Chane Graziano, Chief Executive Officer

HARVARD BIOSCIENCE, INC.


84 October Hill Road

Holliston, Massachusetts 01746

(508) 893-8999

(Name, address, including zip code, and telephone number, including area code, of agent for service)




With copies to:

H. David Henken

Daniel P. Adams

Goodwin Procter LLP

Exchange Place

Boston, Massachusetts 02109-2881

(617) 570-1000




Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.





Large accelerated filer ¨ Accelerated filer x Non-accelerated filer ¨ Smaller reporting company ¨
(Do not check if a smaller reporting company)









Calculation of Registration Fee






Title of Securities

to be Registered
Amount to be
Registered(1)(2) Proposed

Maximum
Offering Price
Per Share(2)
Proposed

Maximum
Aggregate
Offering Price(2)
Amount of
Registration Fee
Common Stock, par value $0.01 per share
2,500,000 shares $ 4.86 $ 12,150,000.00 $ 477.50







(1) This Registration Statement relates to 2,500,000 shares of Common Stock, par value $0.01 per share, of Harvard Bioscience, Inc. (“Common Stock”) available for issuance under the Harvard Bioscience, Inc. Second Amended and Restated 2000 Stock Option and Incentive Plan (together with previous versions of such plan, the “Plan”); plus such indeterminate number of additional shares of Common Stock as may be required pursuant to the Plan in the event of a stock dividend, stock split, split-up, recapitalization or other similar event. This Registration Statement also relates to the Rights to purchase shares of Series A Junior Participating Cumulative Preferred Stock of Harvard Bioscience, Inc. (the “Company”) which are attached to all shares of Common Stock pursuant to the terms of the Company’s Shareholder Rights Agreement dated February 5, 2008. Until the occurrence of certain prescribed events, the Rights are not exercisable, are evidenced by the certificates for the Common Stock and will be transferred only with such stock.


(2) The Company previously filed a Registration Statement on Form S-8 on January 17, 2001 (SEC File No. 333-53848), registering the issuance of 4,849,096 shares of Common Stock under the Plan. On April 15, 2003, the Company filed a Registration Statement on Form S-8 (SEC File No. 333-104544) registering the issuance of 787,413 additional shares of Common Stock under the Plan. On June 28, 2006, the Company filed a Registration Statement on Form S-8 (SEC File No. 333-135418) registering the issuance of 2,067,060 additional shares of Common Stock under the Plan. By filing this Registration Statement in accordance with Instruction E to Form S-8, the Company registers the issuance of the 2,500,000 additional shares of Common Stock approved for issuance under the Plan at the Annual Meeting of Stockholders of the Company held on May 15, 2008.


(3) This estimate is made pursuant to Rule 457(c) and (h) under the Securities Act of 1933, as amended (the “Securities Act”), solely for the purpose of determining the amount of the registration fee. The registration fee is based upon the average of the high and low sales prices for a share of Common Stock on May 15, 2008, as reported on the NASDAQ Global Market.











--------------------------------------------------------------------------------

The Company previously filed a Registration Statement on Form S-8 with the Securities and Exchange Commission on January 17, 2001 (SEC File No. 333-53848) in connection with the Plan (the “Original Filing”). This Registration Statement registers additional shares of the Company’s Common Stock to be issued pursuant to the Plan. The contents of the Original Filing are incorporated by reference into this Registration Statement pursuant to General Instruction E of Form S-8.




PART II

INFORMATION REQUIRED IN THE REGISTRATION STATEMENT




Item 8.

Exhibits


The exhibits listed below represent a complete list of exhibits filed or incorporated by reference as part of this Registration Statement.





(1)3.1
Second Amended and Restated Certificate of Incorporation of Harvard Bioscience, Inc.



(1)3.2
Amended and Restated Bylaws of Harvard Bioscience, Inc.



(2)3.3
Amendment No. 1 to Amended and Restated Bylaws of Harvard Bioscience, Inc. (as adopted October 30, 2007)

(1)4.1
Specimen certificate for shares of Common Stock, $0.01 par value, of Harvard Bioscience, Inc.



(1)4.2
Amended and Restated Securityholders’ Agreement dated as of March 2, 1999 by and among Harvard Apparatus, Inc., Pioneer Partnership II, Pioneer Capital Corp., First New England Capital, L.P. and Citizens Capital, Inc. and Chane Graziano and David Green

(3)4.3
Shareholder Rights Agreement, dated as of February 5, 2008 between Harvard Bioscience, Inc., and Registrar and Transfer Company, as Rights Agent

* 5.1
Legal opinion from Goodwin Procter LLP

* 23.1
Consent of KPMG LLP, as independent registered public accounting firm

23.2
Consent of Goodwin Procter LLP (contained in the opinion filed as Exhibit 5.1 to this Registration Statement)

24.1
Power of attorney (included on the signature page to this Registration Statement)



* Filed herewith.


(1) Previously filed as an exhibit to the Company’s Registration Statement on Form S-1 (File No. 333-45996) and incorporated by reference thereto.


(2) Previously filed as an exhibit to the Company’s Current Report on Form 8-K (filed on November 1, 2007) and incorporated by reference thereto.


(3) Previously filed as an exhibit to the Company’s Current Report on Form 8-K (filed on February 8, 2008) and incorporated by reference thereto.





2



--------------------------------------------------------------------------------




SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, as amended, the Company certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Holliston, Massachusetts, on this 19th day of May, 2008.





HARVARD BIOSCIENCE, INC.



By: / S / Chane Graziano

Chane Graziano
Chief Executive Officer



POWER OF ATTORNEY

KNOW ALL BY THESE PRESENTS that each individual whose signature appears below constitutes and appoints each of Chane Graziano and Susan M. Luscinski as such person’s true and lawful attorney-in-fact and agent with full power of substitution and resubstitution, for such person in such person’s name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement (or any Registration Statement for the same offering that is to be effective upon filing pursuant to Rule 462(b) under the Securities Act of 1933), and to file the same, with all exhibits thereto, and all documents in connection therewith, with the Securities and Exchange Commission, granting unto each said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as such person might or could do in person, hereby ratifying and confirming all that any said attorney-in-fact and agent, or any substitute or substitutes of any of them, may lawfully do or cause to be done by virtue hereof.


Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the date indicated. Each person listed below has signed this Registration Statement as an officer or director of Harvard Bioscience, Inc.




3



--------------------------------------------------------------------------------

Signature
Title
Date


/s/ Chane Graziano
Director and Chief Executive Officer (Principal Executive Officer) May 19, 2008
Chane Graziano

/s/ Susan M. Luscinski
Chief Operating Officer and Treasurer

(Principal Financial Officer and Principal Accounting Officer)
May 19, 2008
Susan M. Luscinski

/s/ Robert Dishman
Director May 19, 2008
Robert Dishman

/s/ Neal J. Harte
Director May 19, 2008
Neal J. Harte

/s/ David Green
Director May 19, 2008
David Green

/s/ John F. Kennedy
Director May 19, 2008
John F. Kennedy

/s/ Earl R. Lewis
Director May 19, 2008
Earl R. Lewis

/s/ George Uveges
Director May 19, 2008
George Uveges




4



--------------------------------------------------------------------------------



EXHIBIT INDEX





Exhibit
Number
Description


(1)3.1
Second Amended and Restated Certificate of Incorporation of Harvard Bioscience, Inc.



(1)3.2
Amended and Restated Bylaws of Harvard Bioscience, Inc.



(2)3.3
Amendment No. 1 to Amended and Restated Bylaws of Harvard Bioscience, Inc. (as adopted October 30, 2007)

(1)4.1
Specimen certificate for shares of Common Stock, $0.01 par value, of Harvard Bioscience, Inc.



(1)4.2
Amended and Restated Securityholders’ Agreement dated as of March 2, 1999 by and among Harvard Apparatus, Inc., Pioneer Partnership II, Pioneer Capital Corp., First New England Capital, L.P. and Citizens Capital, Inc. and Chane Graziano and David Green

(3)4.3
Shareholder Rights Agreement, dated as of February 5, 2008 between Harvard Bioscience, Inc., and Registrar and Transfer Company, as Rights Agent


* 5.1
Legal opinion from Goodwin Procter LLP

* 23.1
Consent of KPMG LLP, as independent registered public accounting firm

23.2
Consent of Goodwin Procter LLP (contained in the opinion filed as Exhibit 5.1 to this Registration Statement)

24.1
Power of attorney (included on the signature page to this Registration Statement)




* Filed herewith.


(1) Previously filed as an exhibit to the Company’s Registration Statement on Form S-1 (File No. 333-45996) and incorporated by reference thereto.


(2) Previously filed as an exhibit to the Company’s Current Report on Form 8-K (filed on November 1, 2007) and incorporated by reference thereto.


(3) Previously filed as an exhibit to the Company’s Current Report on Form 8-K (filed on February 8, 2008) and incorporated by reference thereto.







Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist